Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Pitroda

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Cancer Cell|July 4, 2025
The dark side of radiotherapyAndrás Piffkó, Sean P Pitroda, Ralph R Weichselbaum
International Journal of Molecular Sciences|September 10, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May HoldWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2019
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung CancerCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
Neoplasia (New York, N.Y.)|March 18, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapyWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Aging|April 15, 2015
microRNAs and oligometastasisNikolai N Khodarev, Sean P Pitroda, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Staging the Metastatic Spectrum Through Integration of Clinical and Molecular FeaturesCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2019
Integration of radiotherapy and immunotherapy for treatment of oligometastasesSean P Pitroda, Steven J Chmura, Ralph R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Cancer|December 7, 2018
Oligometastatic prostate cancer: Reality or figment of imagination?Corey C Foster, Ralph R Weichselbaum, Sean P Pitroda
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Cancer Cell|July 4, 2025
The dark side of radiotherapyAndrás Piffkó, Sean P Pitroda, Ralph R Weichselbaum
International Journal of Molecular Sciences|September 10, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May HoldWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2019
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung CancerCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
Neoplasia (New York, N.Y.)|March 18, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapyWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Aging|April 15, 2015
microRNAs and oligometastasisNikolai N Khodarev, Sean P Pitroda, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Staging the Metastatic Spectrum Through Integration of Clinical and Molecular FeaturesCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2019
Integration of radiotherapy and immunotherapy for treatment of oligometastasesSean P Pitroda, Steven J Chmura, Ralph R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Cancer|December 7, 2018
Oligometastatic prostate cancer: Reality or figment of imagination?Corey C Foster, Ralph R Weichselbaum, Sean P Pitroda
Pageof 9